Target intelligence / Profile preview

Mpox virus surface antigen B6R (B6R)

Target
B6R
Molecular classification
Viral surface glycoprotein, Complement control protein (CCP)/sushi domain family, Envelope protein ("Other" if a strict list: non-mammalian/virus structural protein)
01

Overview

B6R is a membrane-associated glycoprotein unique to the extracellular enveloped form of mpox virus (MPXV) and is homologous to the vaccinia virus B5R protein, sharing >96% similarity. It contains an extracellular region with four tandem complement control protein (CCP)/sushi domains and a C-terminal transmembrane helix anchoring it to the viral envelope. B6R undergoes palmitoylation, aiding its trafficking to the EEV membrane where it plays essential roles in viral egress, efficient cell-to-cell spread, and evasion of the host complement cascade. B6R is highly immunogenic and serves as a primary target for neutralizing antibodies, which can protect in animal models and inhibit virus transmission. Antibodies and vaccines targeting B6R are in preclinical and research stages as potential countermeasures for mpox. The B6R gene is also used as a specific molecular diagnostic biomarker for MPXV and is included in PCR-based detection assays.

Other names
B6 proteinOrthopoxvirus EEV glycoprotein B6RMPXV B6RVACV B5R homolog
02

Mechanism of action

Neutralizing antibodies bind B6R to block virus spread and/or mediate immune clearance of EEV; Candidate vaccines generate anti-B6R antibodies for immune protection

03

Biological functions

Viral entry/fusionSurface localization on EEV for infection propagationEvasion of host immune complement systemFormation and release of extracellular enveloped virus (EEV)
04

Disease associations

Infection (Orthopoxvirus, mpox)
05

Safety considerations

No B6R-specific safety issues identified; general considerations for viral protein targeting antibodies (risk of viral escape, rare hypersensitivity)Combination with other antigens (cocktail vaccines) is being tested to minimize escape and enhance efficacy
06

Interacting drugs

neutralizing monoclonal antibodies (e.g., B7C9, hMB621, hMB668, B026, B019)

1 more in the full profile.

07

Biomarkers

B6R mRNA or protein expression used for RT-PCR diagnostic assays (B6R-targeted PCR)Serological response to B6R as biomarker of vaccine or infection status

Beyond the preview

Go deeper on Mpox virus surface antigen B6R (B6R).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mpox virus surface antigen B6R (B6R).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call